Dr Hugh D Mcpherson, MD | |
9777 S Yosemite St, 220, Lone Tree, CO 80124-3191 | |
(303) 699-7325 | |
(303) 699-5486 |
Full Name | Dr Hugh D Mcpherson |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 30 Years |
Location | 9777 S Yosemite St, Lone Tree, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447234281 | NPI | - | NPPES |
19039719 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | DR.0039439 (Colorado) | Secondary |
207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | DR.0039439 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sky Ridge Medical Center | Lone tree, CO | Hospital |
Centura Health-porter Adventist Hospital | Denver, CO | Hospital |
Castle Rock Adventist Hospital | Castle rock, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Orthopedic Centers Of Colorado | 2365714540 | 298 |
News Archive
Johanna Olson, MD, and her colleagues at Children's Hospital Los Angeles, provide care for the largest number of transyouth in the U.S. and have enrolled 101 patients in a study to determine the safety and efficacy of treatment that helps patients bring their bodies into closer alignment with their gender of identity.
Immunotherapy using monoclonal antibodies is a promising treatment strategy, and it might now be within reach: American scientists have successfully prepared an oligosaccharide enterobacterial antigen for which a monoclonal antibody has been developed. The study is published in the journal Angewandte Chemie.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that the U.S. Food and Drug Administration (FDA) has approved XIAFLEX™, a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
› Verified 3 days ago
Entity Name | Portercare Adventist Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
Johanna Olson, MD, and her colleagues at Children's Hospital Los Angeles, provide care for the largest number of transyouth in the U.S. and have enrolled 101 patients in a study to determine the safety and efficacy of treatment that helps patients bring their bodies into closer alignment with their gender of identity.
Immunotherapy using monoclonal antibodies is a promising treatment strategy, and it might now be within reach: American scientists have successfully prepared an oligosaccharide enterobacterial antigen for which a monoclonal antibody has been developed. The study is published in the journal Angewandte Chemie.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that the U.S. Food and Drug Administration (FDA) has approved XIAFLEX™, a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
› Verified 3 days ago
Entity Name | Orthopedic Centers Of Colorado |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801339502 PECOS PAC ID: 2365714540 Enrollment ID: O20170823001317 |
News Archive
Johanna Olson, MD, and her colleagues at Children's Hospital Los Angeles, provide care for the largest number of transyouth in the U.S. and have enrolled 101 patients in a study to determine the safety and efficacy of treatment that helps patients bring their bodies into closer alignment with their gender of identity.
Immunotherapy using monoclonal antibodies is a promising treatment strategy, and it might now be within reach: American scientists have successfully prepared an oligosaccharide enterobacterial antigen for which a monoclonal antibody has been developed. The study is published in the journal Angewandte Chemie.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that the U.S. Food and Drug Administration (FDA) has approved XIAFLEX™, a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Hugh D Mcpherson, MD 9777 S Yosemite St, 220, Lone Tree, CO 80124-3191 Ph: (303) 699-7325 | Dr Hugh D Mcpherson, MD 9777 S Yosemite St, 220, Lone Tree, CO 80124-3191 Ph: (303) 699-7325 |
News Archive
Johanna Olson, MD, and her colleagues at Children's Hospital Los Angeles, provide care for the largest number of transyouth in the U.S. and have enrolled 101 patients in a study to determine the safety and efficacy of treatment that helps patients bring their bodies into closer alignment with their gender of identity.
Immunotherapy using monoclonal antibodies is a promising treatment strategy, and it might now be within reach: American scientists have successfully prepared an oligosaccharide enterobacterial antigen for which a monoclonal antibody has been developed. The study is published in the journal Angewandte Chemie.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that the U.S. Food and Drug Administration (FDA) has approved XIAFLEX™, a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
› Verified 3 days ago
John R Barker, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10103 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 303-225-8120 Fax: 303-225-8130 | |
Dr. Leonard Wade Faulk, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Dr. Edward S Szuszczewicz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10099 Ridge Gate Pkwy, Suite 310, Lone Tree, CO 80124 Phone: 303-790-1800 Fax: 719-368-6870 | |
Dr. Cale W Bonds, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Dr. Paul V Hautamaa, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Mark S Fitzgerald, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9777 S Yosemite St, Suite 220, Lone Tree, CO 80124 Phone: 303-699-7325 Fax: 303-699-5486 | |
Eric R Jamrich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10103 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 303-225-8120 Fax: 303-225-8130 |